These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26192013)

  • 1. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
    Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA
    Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
    Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S
    Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
    Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.
    Schloer S; Goretzko J; Kühnl A; Brunotte L; Ludwig S; Rescher U
    Emerg Microbes Infect; 2019; 8(1):80-93. PubMed ID: 30866762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening.
    Weisshaar M; Cox R; Morehouse Z; Kyasa SK; Yan D; Oberacker P; Mao S; Golden JE; Lowen AC; Natchus MG; Plemper RK
    J Virol; 2016 Aug; 90(16):7368-7387. PubMed ID: 27252534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
    An L; Liu R; Tang W; Wu JG; Chen X
    Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging cellular targets for influenza antiviral agents.
    Müller KH; Kakkola L; Nagaraj AS; Cheltsov AV; Anastasina M; Kainov DE
    Trends Pharmacol Sci; 2012 Feb; 33(2):89-99. PubMed ID: 22196854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Small-Molecule Control of Influenza A Virus Replication.
    Fay EJ; Aron SL; Stone IA; Waring BM; Plemper RK; Langlois RA
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30282710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
    Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
    Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
    Lesch M; Luckner M; Meyer M; Weege F; Gravenstein I; Raftery M; Sieben C; Martin-Sancho L; Imai-Matsushima A; Welke RW; Frise R; Barclay W; Schönrich G; Herrmann A; Meyer TF; Karlas A
    PLoS Pathog; 2019 Mar; 15(3):e1007601. PubMed ID: 30883607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
    Chen SC; Jeng KS; Lai MMC
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity.
    Khalil H; Abd El Maksoud AI; Roshdey T; El-Masry S
    J Med Virol; 2019 Jan; 91(1):45-55. PubMed ID: 30153335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far?
    Morrison J; Katze MG
    Expert Opin Ther Targets; 2015 Apr; 19(4):447-50. PubMed ID: 25600759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
    Eichelberger MC; Hassantoufighi A; Wu M; Li M
    Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics.
    Ulyanova V; Shah Mahmud R; Laikov A; Dudkina E; Markelova M; Mostafa A; Pleschka S; Ilinskaya O
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation.
    Choi MS; Heo J; Yi CM; Ban J; Lee NJ; Lee NR; Kim SW; Kim NJ; Inn KS
    Biochem Biophys Res Commun; 2016 Aug; 477(3):311-6. PubMed ID: 27346133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.